Quantbot Technologies LP Karuna Therapeutics, Inc. Transaction History

Quantbot Technologies LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 08, 2023	BUY	$176.32 - $240.22 $89,217 - $121,551	506 New	506 $109,000
Q4 2022 Feb 13, 2023	SELL	$191.53 - $236.82 $1.26 Million - $1.56 Million	-6,571 Reduced 96.33%	250 $49,000
Q3 2022 Nov 07, 2022	BUY	$123.79 - $277.42 $844,371 - $1.89 Million	6,821 New	6,821 $1.53 Million
Q1 2022 May 16, 2022	SELL	$98.9 - $132.37 $9,890 - $13,237	-100 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$110.64 - $159.4 $55,320 - $79,700	-500 Reduced 83.33%	100 $13,000
Q3 2021 Nov 09, 2021	SELL	$101.2 - $125.87 $20,240 - $25,174	-200 Reduced 25.0%	600 $73,000
Q2 2021 Aug 12, 2021	BUY	$107.45 - $135.95 $85,960 - $108,759	800 New	800 $91,000
Q4 2020 Feb 12, 2021	SELL	$75.23 - $109.23 $7,523 - $10,923	-100 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$71.31 - $109.74 $7,131 - $10,974	100 New	100 $7,000

332K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.